Efavirenz

Educational summary, not a formulary. Dosing is quoted from the Makindo chapters and topics site. The other sections are draft summaries not yet checked line by line against the BNF or SPC. Check dose, indication, interactions and monitoring in the BNF entry for Efavirenz and local guidelines before prescribing.

Non-nucleoside reverse transcriptase inhibitor

Mechanism

Non-nucleoside reverse transcriptase inhibitor.

Uses

HIV infection.

Dosing

No dose is given in the chapters. See the BNF.

Side effects

Dizziness, vivid dreams, depression, rash, hepatotoxicity.

Interactions

CYP3A4 inducer reducing many drug levels; QT-prolonging drugs.

Contraindications and cautions

Psychiatric illness, severe liver disease

Monitoring

LFT, mood, lipids

Pregnancy and breastfeeding

Avoid in first trimester

Renal and hepatic impairment

Caution in hepatic impairment

Overdose and reversal

Supportive

Special advice

Take at night; hormonal contraception less effective.

More from the textbook: uses, cautions and other points
Where it is discussed in the book